Catalyst Wire Dossier Catalyst Wire Dossier

Efavaleukin Alfa

efavaleukin alfa · Amgen
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Efavaleukin Alfa, covering 2021-06-04 to 2026-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis [Phase 2]

See pricing